Mohamed G. Atta

5.4k total citations
119 papers, 3.1k citations indexed

About

Mohamed G. Atta is a scholar working on Infectious Diseases, Nephrology and Emergency Medicine. According to data from OpenAlex, Mohamed G. Atta has authored 119 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Infectious Diseases, 43 papers in Nephrology and 37 papers in Emergency Medicine. Recurrent topics in Mohamed G. Atta's work include HIV/AIDS drug development and treatment (45 papers), HIV-related health complications and treatments (36 papers) and Renal Diseases and Glomerulopathies (31 papers). Mohamed G. Atta is often cited by papers focused on HIV/AIDS drug development and treatment (45 papers), HIV-related health complications and treatments (36 papers) and Renal Diseases and Glomerulopathies (31 papers). Mohamed G. Atta collaborates with scholars based in United States, Egypt and United Kingdom. Mohamed G. Atta's co-authors include Derek M. Fine, Gregory M. Lucas, Paul J. Scheel, Stephanie M. Toth‐Manikowski, Michelle M. Estrella, Lorraine C. Racusen, Richard D. Moore, M. Hafizur Rahman, Michael Choi and H. Moo Kwon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Mohamed G. Atta

111 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed G. Atta United States 32 1.3k 998 994 552 545 119 3.1k
Michael Fischereder Germany 30 345 0.3× 152 0.2× 611 0.6× 319 0.6× 602 1.1× 121 3.3k
Minoru Ando Japan 25 273 0.2× 207 0.2× 387 0.4× 283 0.5× 219 0.4× 99 1.6k
Yingyos Avihingsanon Thailand 31 270 0.2× 88 0.1× 688 0.7× 498 0.9× 311 0.6× 159 2.9k
Julie Ho Canada 28 166 0.1× 126 0.1× 1.1k 1.1× 233 0.4× 718 1.3× 88 3.8k
P. Sweny United Kingdom 35 303 0.2× 72 0.1× 858 0.9× 192 0.3× 1.2k 2.1× 120 3.5k
Fernando Liaño Spain 25 90 0.1× 460 0.5× 2.0k 2.0× 282 0.5× 563 1.0× 97 3.0k
Jean‐Claude Roujeau France 47 445 0.3× 76 0.1× 218 0.2× 160 0.3× 1.2k 2.2× 116 9.2k
William A. Briggs United States 23 143 0.1× 124 0.1× 599 0.6× 210 0.4× 157 0.3× 55 1.6k
Charles F. Arkin United States 17 165 0.1× 117 0.1× 95 0.1× 332 0.6× 280 0.5× 38 1.8k
Ryutaro Hirose United States 36 282 0.2× 97 0.1× 278 0.3× 289 0.5× 1.4k 2.6× 140 4.9k

Countries citing papers authored by Mohamed G. Atta

Since Specialization
Citations

This map shows the geographic impact of Mohamed G. Atta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed G. Atta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed G. Atta more than expected).

Fields of papers citing papers by Mohamed G. Atta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed G. Atta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed G. Atta. The network helps show where Mohamed G. Atta may publish in the future.

Co-authorship network of co-authors of Mohamed G. Atta

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed G. Atta. A scholar is included among the top collaborators of Mohamed G. Atta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed G. Atta. Mohamed G. Atta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cervantes, C. Elena & Mohamed G. Atta. (2024). Kidney Amyloidosis: Updates on Pathogenesis and Therapeutic Frontiers. American Journal of Nephrology. 1–12. 1 indexed citations
2.
Hodgin, Jeffrey B., Avi Z. Rosenberg, Laurence S. Magder, et al.. (2023). POS0297 PROTEOMIC ANALYSIS OF HISTOLOGICAL LESIONS LUPUS NEPHRITIS IDENTIFIES AN INFLAMMATORY SIGNATURE OF FIBROUS CRESCENTS. Annals of the Rheumatic Diseases. 82. 390–391. 1 indexed citations
3.
Hughes, Derralynn, Derlis Gonzalez, Gustavo Maegawa, et al.. (2023). Long-term safety and efficacy of pegunigalsidase alfa: A multicenter 6-year study in adult patients with Fabry disease. Genetics in Medicine. 25(12). 100968–100968. 20 indexed citations
4.
Cervantes, C. Elena, Sam Kant, & Mohamed G. Atta. (2021). The Link Between Conventional and Novel Anti-Cancer Therapeutics with Thrombotic Microangiopathy. Drug Metabolism Letters. 14(2). 97–105. 1 indexed citations
5.
Rossi, Giovanni Maria, Francesco Peyronel, Steven Menez, et al.. (2020). Low-Level Proteinuria in Systemic Lupus Erythematosus. Kidney International Reports. 5(12). 2333–2340. 32 indexed citations
6.
Menez, Steven, et al.. (2018). HIV-associated nephropathy: links, risks and management. HIV/AIDS - Research and Palliative Care. Volume 10. 73–81. 16 indexed citations
7.
Swaminathan, Madhav, Mark Stafford‐Smith, Glenn M. Chertow, et al.. (2017). Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. Journal of the American Society of Nephrology. 29(1). 260–267. 95 indexed citations
8.
Warnock, David G., Derralynn Hughes, Pilar Giraldo, et al.. (2017). PRX-102 for treating Fabry disease: immunogenicity and PK results from a phase 1-2 study. Molecular Genetics and Metabolism. 120(1-2). S137–S138. 2 indexed citations
9.
Slaven, James E., Brian S. Decker, Angela D. M. Kashuba, et al.. (2016). Plasma and Intracellular Concentrations in HIV-infected Patients Requiring Hemodialysis Dosed with Tenofovir Disoproxil Fumarate and Emtricitabine. PMC. 1 indexed citations
10.
Atta, Mohamed G., Michelle M. Estrella, Michael Kuperman, et al.. (2012). HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney International. 82(3). 338–343. 41 indexed citations
11.
Lucas, Gregory M., et al.. (2010). Characteristics of Patients with HIV and Biopsy-Proven Acute Interstitial Nephritis. Clinical Journal of the American Society of Nephrology. 5(5). 798–804. 35 indexed citations
12.
Lucas, Gregory M., Bryan Lau, Mohamed G. Atta, et al.. (2008). Chronic Kidney Disease Incidence, and Progression to End‐Stage Renal Disease, in HIV‐Infected Individuals: A Tale of Two Races. The Journal of Infectious Diseases. 197(11). 1548–1557. 166 indexed citations
13.
Sperati, C. John, et al.. (2008). Fibromuscular dysplasia. Kidney International. 75(3). 333–336. 13 indexed citations
14.
Fine, Derek M. & Mohamed G. Atta. (2007). Review: Kidney Disease in the HIV-Infected Patient. AIDS Patient Care and STDs. 21(11). 813–824. 26 indexed citations
15.
Fine, Derek M., Neha Garg, Mark Haas, et al.. (2007). Cocaine Use and Hypertensive Renal Changes in HIV-Infected Individuals. Clinical Journal of the American Society of Nephrology. 2(6). 1125–1130. 22 indexed citations
16.
Lucas, Gregory M., Shruti H. Mehta, Mohamed G. Atta, et al.. (2007). End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 21(18). 2435–2443. 109 indexed citations
17.
Fradley, Michael G., Jeffrey Liu, & Mohamed G. Atta. (2005). Primary Aldosteronism with HIV Infection: Important Considerations When Using the Aldosterone:Renin Ratio to Screen This Unique Population. American Journal of Therapeutics. 12(4). 368–374. 3 indexed citations
18.
Melamed, Michal L., Hyun S. Kim, Bernard G. Jaar, et al.. (2005). Combined Percutaneous Mechanical and Chemical Thrombectomy for Renal Vein Thrombosis in Kidney Transplant Recipients. American Journal of Transplantation. 5(3). 621–626. 30 indexed citations
19.
Atta, Mohamed G., Stephen C. Dahl, H. Moo Kwon, & Joseph S. Handler. (1999). Tyrosine kinase inhibitors and immunosuppressants perturb the myo-inositol but not the betaine cotransporter in isotonic and hypertonic MDCK cells. Kidney International. 55(3). 956–962. 19 indexed citations
20.
Sobh, Mohamed, et al.. (1992). Effect of Treatment of Anaemia with Erythropoietin on Neuromuscular Function in Patients on Long Term Haemodialysis. Scandinavian Journal of Urology and Nephrology. 26(1). 65–69. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Fischereder Breakdown of academic impact, for papers by Minoru Ando Breakdown of academic impact, for papers by Yingyos Avihingsanon Breakdown of academic impact, for papers by Julie Ho Breakdown of academic impact, for papers by P. Sweny Breakdown of academic impact, for papers by Fernando Liaño Breakdown of academic impact, for papers by Jean‐Claude Roujeau Breakdown of academic impact, for papers by William A. Briggs Breakdown of academic impact, for papers by Charles F. Arkin Breakdown of academic impact, for papers by Ryutaro Hirose
Rankless by CCL
2026